Status:
COMPLETED
The Effect of Renastart Formula Supplementation in Children With Acute Kidney Injury in Maintaining Normal Serum Electrolytes Levels
Lead Sponsor:
Ain Shams University
Conditions:
Acute Kidney Injury
Eligibility:
All Genders
1-10 years
Phase:
NA
Brief Summary
This clinical trial will evaluate Renastart formula effectiveness in children with acute kidney injury (AKI) and acute on top of chronic kidney disease (CKD), in maintaining normal serum electrolytes ...
Eligibility Criteria
Inclusion
- •Infants and Children with AKI and acute on top of CKD Suffering from hyperkalemia and/or hyperphosphatemia at Pediatric Nephrology Unit (PNU), Children's Hospital, Ain Shams University Hospitals.
Exclusion
- Patients are on dialysis.
- Pediatric patients with coexisting another medical problems and different risk factors which can affect serum electrolytes such as: Constipation, high volume blood transfusion and Diabetes medications disrupt potassium balance e.g., ACEI, ARBS and Diuretics.
Key Trial Info
Start Date :
February 12 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT06218212
Start Date
February 12 2022
End Date
June 30 2023
Last Update
February 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine-Ain Shams University
Cairo, Abbasia, Egypt, 1181